NIVF Market Analysis
News & Sentiment
50 articles · sorted by dateVia 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
Fundamentals
Updated daily after market closeValuation
- Forward P/E
- 0.06
- PEG ratio
- —
- P/B
- 0.10
- P/S (TTM)
- 0.59
- EV/EBITDA
- 0.63
Profitability & growth
- ROE (TTM)
- 79.4%
- Operating margin
- -349.1%
- Revenue growth YoY
- 11.9%
- Dividend yield
- —
- Beta
- -0.04
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
About NewGenIvf Group Limited Class A Ordinary Shares
Company profileNewGenIvf Group Limited (NIVF) is a pioneering organization in the reproductive health industry, specializing in innovative fertility solutions, including advanced in vitro fertilization (IVF) services. The company is dedicated to enhancing success rates in assisted reproductive technologies and is strategically positioned to capitalize on the growing global demand for fertility treatments, supported by a robust network of clinics and strategic partnerships. As the fertility services market continues to expand, NIVF is well-equipped for substantial growth, with a mission to assist individuals…
Classification
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Exchange
- NASDAQ
- Country
- USA
- Currency
- USD
Company profile
- HQ
- PS TOWER, BANGKOK, THAILAND
- Fiscal year end
- December
- Latest quarter
- Dec 31, 2025
We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer
